Sei Investments CO Aldeyra Therapeutics, Inc. Transaction History

Sei Investments CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$7.94 - $11.31 $551,814 - $786,022	-69,498 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$10.44 - $14.85 $725,559 - $1.03 Million	69,498 New	69,498 $787,000
Q1 2019 May 15, 2019	SELL	$7.14 - $9.85 $460,815 - $635,719	-64,540 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$7.26 - $13.29 $468,560 - $857,736	64,540 New	64,540 $536,000

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $280M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.